Montage Resources Corp
Change company Symbol lookup
Select an option...
MR Montage Resources Corp
AMAG AMAG Pharmaceuticals Inc
HCI Hci Group Inc
PSF Cohen & Steers Select Preferred and Income Fund
PJT PJT Partners Inc
ALK Alaska Air Group Inc
RS Reliance Steel & Aluminum Co
HFWA Heritage Financial Corp
MET MetLife Inc
KALU Kaiser Aluminum Corp
Go

Energy : Oil, Gas & Consumable Fuels | Small Cap Value
Company profile

Montage Resources Corp, formerly Eclipse Resources Corp, is an independent exploration and production company. The Company is engaged in the acquisition and development of oil and natural gas properties in the Appalachian Basin. It is the operator of the Utica Core Area and its Marcellus Project Area. The Ordovician-aged Utica Shale is an unconventional reservoir consisting of organic-rich black shale, with production occurring at vertical depths between 6,000 and 10,000 feet. The Marcellus Shale consists of organic-rich black shale, with production occurring at vertical depths between 5,000 and 8,000 feet. As of December 31, 2016, it had approximately 92,000 net acres in the Utica Shale in Eastern Ohio within the Utica Core Area. As of December 31, 2016, the Company had assembled an acreage position approximating 199,000 net acres in Eastern Ohio.

Closing Price
$5.78
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.96
Day's Low
5.67
Volume
(Above Average)
Volume:
499,161

10-day average volume:
430,428
499,161

Robust Research & Development Results In Faster Growth Of The Global Biologics Market

10:00 am ET October 14, 2020 (Globe Newswire) Print

The biologics market is highly concentrated, with a small number of large players. The top ten competitors in the market made up 67.4% of the total market. Major players in the market include Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Merck & Co., Inc., Johnson & Johnson, and others.

The Business Research Company's report titled Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies - Global Forecast To 2021 covers major biologics companies, biologics market share by company, biologics manufacturers, biologics market size, and biologics market forecasts.

This report describes and evaluates the global biologics market. It covers 2015 to 2019, termed the historic period, and 2019 to 2023 termed the forecast period, along with further forecasts for the periods 2023-2025 and 2025-2030. The biologics market consists of sales of biologics and related services by entities that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The report also covers the global biologics market and its segments.

The biologics market is segmented by type into monoclonal antibodies, therapeutic proteins, and vaccines. The monoclonal antibodies market was the largest segment of the biologics market segmented by type, accounting for 42.6% of the total biologics market. The top opportunities in the biologics market segmented by type will arise in the monoclonal antibodies segment, which will gain $83 billion of global annual sales by 2023.

Impact Of COVID-19 On The Global Biologic Market 2020

Amidst the unprecedented outbreak of coronavirus, governments across the world are advising people to stay indoors and practice social distancing, to reduce the spread of the pandemic. Increasing funding from public and private organizations for the development of vaccines against COVID-19 is expected to drive the market in the forecast period.

A large amount of funding from the public and private organizations accelerate the process of drug development and supports research on new drugs. The impact of COVID-19 on the global biologics market is quite significant. With the increasing number of COVID-19 positive cases, pharmaceutical companies and research organizations are working to develop a reliable treatment for the disease.

Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies - Global Forecast To 2021 is one of a series of new reports from The Business Research Company that provide biologics market overviews, analyze and forecast market size and growth for the whole market, biologics market segments and geographies, biologics market trends, biologics market drivers, biologics market restraints, biologics market leading competitors' revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives an in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors' approaches.

Here Is A List Of Similar Reports By The Business Research Company:

COVID-19 Rapid Test Kits Market - Opportunities And Strategies - Global Forecast To 2023

Oncology Drugs Market - Opportunities And Strategies - Global Forecast To 2030

Pharmaceuticals Market - Opportunities And Strategies - Global Forecast To 2030

Oral Biologics And Biosimilars Market Opportunities And Strategies - Global Forecast To 2030

Pharmaceutical Drugs Market - Opportunities And Strategies - Global Forecast To 2030

Pharmaceutical Drugs And Biologics Logistics Market - Opportunities And Strategies - Global Forecast To 2021

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

The global biologics market reached a value of nearly

https://ml.globenewswire.com/media/3bf07720-8041-4b6e-84f3-8c3f28854315/small/the-business-research-company-horizontal-logo-2-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.